A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors
Stephen Ansell, Donald Northfelt, Ian Flinn, Howard Burris, Shira Dinner, Victor Villalobos, Branimir Sikic, Lana Pilja, Michael Yellin, Tibor Keler, Thomas Davis
Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P259; DOI: 10.1186/2051-1426-1-S1-P259